HB 1464-FN (2020): relative to insurance coverage for yoga therapy as an alternative or substitute for opioids.
Cite this page
Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.
- MLA
- “HB 1464-FN (2020): relative to insurance coverage for yoga therapy as an alternative or substitute for opioids.” Granite Record, https://graniterecord.org/bill/2020/hb1464. Accessed 24 Oct. 2026.
- APA
- Granite Record. (n.d.). HB 1464-FN (2020): relative to insurance coverage for yoga therapy as an alternative or substitute for opioids. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2020/hb1464
- Chicago
- Granite Record. “HB 1464-FN (2020): relative to insurance coverage for yoga therapy as an alternative or substitute for opioids.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2020/hb1464.
- BibTeX
@misc{bill-2020-hb1464, title = {HB 1464-FN (2020): relative to insurance coverage for yoga therapy as an alternative or substitute for opioids.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2020/hb1464}, note = {Accessed 24 Oct. 2026} }
HB 1464-FN (2020)
relative to insurance coverage for yoga therapy as an alternative or substitute for opioids.
- Status: Referred for interim study
- Term: 2019-2020
- House committee: Commerce and Consumer Affairs
- Subject: Insurance
The Story
It was introduced on January 8, 2020 and referred to the House Commerce and Consumer Affairs committee. The committee held a public hearing on February 5, 2020. The committee held a work session on February 14, 2020. The committee met in executive session on February 18, 2020 to vote on its recommendation. The committee voted 18–1 to recommend that the House study it after the session ends, and the report was placed on the consent calendar. On March 12, 2020 the House voted to study it after the session ends on a voice vote. The committee held a work session on September 1, 2020. The committee reported back on its interim study of the bill: “Not Recommended for Future Legislation”, by a vote of 14 to 1.
Sponsors
- Rep. Latha Mangipudi (D - Hills 35) (prime sponsor)
- Rep. Robert Renny Cushing (D - Rock 21)
- Rep. Linda Massimilla (D - Graf 1)
Hearings and Sessions
- February 5, 2020, 10:00 AM: public hearing, House Commerce and Consumer Affairs, LOB 302
- February 14, 2020, 9:30 AM: subcommittee work session, House Commerce and Consumer Affairs, LOB 302
- February 18, 2020, 1:00 PM: executive session, House Commerce and Consumer Affairs, LOB 302
- September 1, 2020, 2:00 PM: full committee work session, House Commerce and Consumer Affairs
Votes
- March 12, 2020, House: Refer for Interim Study — voice vote, passed
The Docket
- January 8, 2020: Introduced 01/08/2020 and referred to Commerce and Consumer Affairs
- February 5, 2020: Public Hearing: 02/05/2020 10:00 am LOB 302
- February 14, 2020: Subcommittee Work Session: 02/14/2020 09:30 am LOB 302
- February 18, 2020: Executive Session: 02/18/2020 01:00 pm LOB 302
- March 11, 2020: Committee Report: Refer for Interim Study for 03/11/2020 (Vote 18-1; CC)
- March 11, 2020: Removed from Consent (Rep. Sylvia) 03/11/2020
- March 12, 2020: Refer for Interim Study: MA VV 03/12/2020
- September 1, 2020: Full Committee Work Session: 09/01/2020 02:00 pm Members of the public may attend using this link: https://www.zoom.us/j/99708430633 - Executive Session to Follow
- October 29, 2020: Interim Study Report: Not Recommended for Future Legislation (Vote 14-1)